Jaime A Cardona-Ospina1, Wilmer E Villamil-Gómez2, Carlos E Jimenez-Canizales3, Diana M Castañeda-Hernández4, Alfonso J Rodríguez-Morales5. 1. Research Group Public Health and Infection, Faculty of Health Sciences, Universidad Tecnológica de Pereira, 660003, Pereira, Risaralda, Colombia. 2. Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre, Colombia Programa del Doctorado de Medicina Tropical, Universidad de Cartagena, Cartagena, Universidad del Atlántico, Barranquilla, Colombia Committee on Zoonoses and Haemorrhagic Fevers, Asociación Colombiana de Infectología (ACIN), Bogota, DC, Colombia. 3. Research Group Public Health and Infection, Faculty of Health Sciences, Universidad Tecnológica de Pereira, 660003, Pereira, Risaralda, Colombia ESE Hospital Santa Barbara, Venadillo, Tolima, Colombia. 4. Research Group Public Health and Infection, Faculty of Health Sciences, Universidad Tecnológica de Pereira, 660003, Pereira, Risaralda, Colombia Fundación Universitaria del Área Andina, Seccional Pereira, Pereira, Risaralda, Colombia. 5. Research Group Public Health and Infection, Faculty of Health Sciences, Universidad Tecnológica de Pereira, 660003, Pereira, Risaralda, Colombia Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre, Colombia Committee on Zoonoses and Haemorrhagic Fevers, Asociación Colombiana de Infectología (ACIN), Bogota, DC, Colombia Fundación Universitaria del Área Andina, Seccional Pereira, Pereira, Risaralda, Colombia Organización Latinoamericana para el Fomento de la Investigación en Salud (OLFIS), Bucaramanga, Santander, Colombia arodriguezm@utp.edu.co.
Abstract
BACKGROUND: Chikungunya (CHIK) virus disease is expected to be a considerable cause of disability and economic burden in Latin America given its chronic sequelae, particularly its chronic inflammatory rheumatism. There have been no previous studies assessing CHIK costs and disability in Latin America. METHODS: We calculated incidence rates for CHIK during the 2014 outbreak in Colombia using epidemiological data provided by the Colombian National Institute of Health, using demographic data from the National Administrative Department of Statistics. The burden of disease was estimated through disability adjusted life years (DALYs) lost and the costs were estimated based on the national recommendations for CHIK acute and chronic phase attention. RESULTS: There were a total of 106 592 cases, with incidence rates ranging from 0 to 1837.3 cases/100 000 population in different departments. An estimate was made of total DALYs lost of 40.44 to 45.14 lost/100 000 population. The 2014 outbreak estimated costs were at least US$73.6 million. CONCLUSIONS: Our estimates raise concerns about the effects of continued CHIK spread in Colombia and other Latin-American countries. The lack of transmission control for this disease and potential for spread means that there will be significant acute and chronic disability and related costs in the short and long term for Latin American health care systems.
BACKGROUND:Chikungunya (CHIK) virus disease is expected to be a considerable cause of disability and economic burden in Latin America given its chronic sequelae, particularly its chronic inflammatory rheumatism. There have been no previous studies assessing CHIK costs and disability in Latin America. METHODS: We calculated incidence rates for CHIK during the 2014 outbreak in Colombia using epidemiological data provided by the Colombian National Institute of Health, using demographic data from the National Administrative Department of Statistics. The burden of disease was estimated through disability adjusted life years (DALYs) lost and the costs were estimated based on the national recommendations for CHIK acute and chronic phase attention. RESULTS: There were a total of 106 592 cases, with incidence rates ranging from 0 to 1837.3 cases/100 000 population in different departments. An estimate was made of total DALYs lost of 40.44 to 45.14 lost/100 000 population. The 2014 outbreak estimated costs were at least US$73.6 million. CONCLUSIONS: Our estimates raise concerns about the effects of continued CHIK spread in Colombia and other Latin-American countries. The lack of transmission control for this disease and potential for spread means that there will be significant acute and chronic disability and related costs in the short and long term for Latin American health care systems.
Authors: Alfonso J Rodriguez-Morales; Victor Manuel Restrepo-Posada; Nathalia Acevedo-Escalante; Esteban David Rodríguez-Muñoz; Manuela Valencia-Marín; Juan D Castrillón-Spitia; José J Londoño; Hector D Bedoya-Rendón; Javier de Jesús Cárdenas-Pérez; Jaime A Cardona-Ospina; Guillermo J Lagos-Grisales Journal: Rheumatol Int Date: 2017-08-21 Impact factor: 2.631
Authors: Kathryn S Carpentier; Ryan M Sheridan; Cormac J Lucas; Bennett J Davenport; Frances S Li; Erin D Lucas; Mary K McCarthy; Glennys V Reynoso; Nicholas A May; Beth A J Tamburini; Jay R Hesselberth; Heather D Hickman; Thomas E Morrison Journal: EMBO J Date: 2021-10-07 Impact factor: 14.012
Authors: Matthew T Aliota; Emma C Walker; Alexander Uribe Yepes; Ivan Dario Velez; Bruce M Christensen; Jorge E Osorio Journal: PLoS Negl Trop Dis Date: 2016-04-28
Authors: Lorenzo Zammarchi; Claudia Fortuna; Giulietta Venturi; Francesca Rinaldi; Teresa Capobianco; Maria Elena Remoli; Gian Maria Rossolini; Giovanni Rezza; Alessandro Bartoloni Journal: Emerg Infect Dis Date: 2016-11-15 Impact factor: 6.883